Zacks Research Has Negative Outlook for Clorox Q1 Earnings

The Clorox Company (NYSE:CLX) – Research analysts at Zacks Research cut their Q1 2027 earnings per share (EPS) estimates for shares of Clorox in a research note issued on Tuesday, February 17th. Zacks Research analyst Team now forecasts that the company will earn $1.31 per share for the quarter, down from their prior forecast of $1.32. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Clorox’s current full-year earnings is $7.15 per share. Zacks Research also issued estimates for Clorox’s Q4 2027 earnings at $2.30 EPS, Q1 2028 earnings at $1.37 EPS and FY2028 earnings at $7.23 EPS.

CLX has been the topic of several other research reports. Wall Street Zen upgraded Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Barclays reissued an “underweight” rating and set a $109.00 price objective on shares of Clorox in a report on Friday, January 16th. UBS Group lifted their target price on Clorox from $115.00 to $121.00 and gave the company a “neutral” rating in a report on Wednesday, February 4th. Wells Fargo & Company set a $125.00 price target on Clorox in a research report on Tuesday. Finally, BNP Paribas Exane upgraded shares of Clorox from an “underperform” rating to a “neutral” rating in a research report on Wednesday, February 11th. One equities research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce” and an average target price of $118.73.

Clorox Stock Performance

Shares of CLX stock opened at $123.51 on Friday. The firm’s 50 day moving average is $109.75 and its 200 day moving average is $113.68. The stock has a market capitalization of $14.93 billion, a P/E ratio of 20.18, a PEG ratio of 0.60 and a beta of 0.59. Clorox has a 12 month low of $96.66 and a 12 month high of $159.04. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing the consensus estimate of $1.43 by ($0.04). The firm had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 383.01% and a net margin of 11.17%.The company’s revenue was down .8% compared to the same quarter last year. During the same period last year, the business posted $1.55 EPS.

Hedge Funds Weigh In On Clorox

Hedge funds and other institutional investors have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Clorox by 4.0% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after acquiring an additional 514 shares in the last quarter. Woodline Partners LP lifted its stake in Clorox by 253.7% during the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock worth $1,532,000 after purchasing an additional 7,465 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Clorox in the 2nd quarter worth about $216,000. Chicago Partners Investment Group LLC increased its position in shares of Clorox by 29.7% during the 2nd quarter. Chicago Partners Investment Group LLC now owns 2,514 shares of the company’s stock valued at $330,000 after purchasing an additional 575 shares during the last quarter. Finally, Stephens Inc. AR raised its holdings in shares of Clorox by 32.4% during the 2nd quarter. Stephens Inc. AR now owns 3,778 shares of the company’s stock valued at $454,000 after buying an additional 924 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Key Stories Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Zacks raised its FY2028 EPS view to $7.23 and upgraded select quarterly/annual estimates (including Q1 2028 to $1.37 and Q4 2026/2027 increases), signaling modestly better forward earnings visibility that can support the stock.
• Positive Sentiment: Clorox published a consumer research report “Home Care Redefined” that underscores evolving demand for wellness- and convenience-oriented home-care products — a strategic tailwind for branded consumer staples. Home Care Redefined
• Neutral Sentiment: Management presented at the Consumer Analyst Group of New York (CAGNY) conference; slides and prepared remarks provide more detail on strategy, cost actions and growth initiatives — useful for longer-term positioning but not an immediate earnings surprise. CAGNY Slides Transcript
• Negative Sentiment: Zacks trimmed multiple near-term quarterly EPS forecasts (several Q2–Q3 2026/2027 cuts and FY2027 lowered to $6.74), reflecting caution about near-term volume/mix or cost pressure — a potential headwind for sentiment and short-term guidance expectations.
• Negative Sentiment: Wells Fargo issued a “Hold” on CLX (reported as “receives a Hold”), which keeps sell-side sentiment neutral-to-cautious and may limit near-term upside from upgrades. Wells Fargo Hold

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.